Viewing Study NCT02202993


Ignite Creation Date: 2025-12-25 @ 12:59 AM
Ignite Modification Date: 2026-03-21 @ 6:12 AM
Study NCT ID: NCT02202993
Status: COMPLETED
Last Update Posted: 2019-07-24
First Post: 2014-07-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TAU-2014-1: Mibefradil and Hypofractionated Re-Irradiation Therapy in Recurrent GBM
Sponsor: Cavion, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 1406014067
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View